This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Nov 1;178(11):1457.

doi: 10.1001/jamainternmed.2018.3930.

Clinical Trials-We Get What We Pay For

Joseph S Ross^{1

2}

Affiliations

Affiliations

¹ Section of General Internal Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
² Associate Editor, , Chicago, Illinois.

PMID: 30264093
DOI: 10.1001/jamainternmed.2018.3930

Comment

Clinical Trials-We Get What We Pay For

Joseph S Ross. JAMA Intern Med. 2018.

. 2018 Nov 1;178(11):1457.

doi: 10.1001/jamainternmed.2018.3930.

Author

Joseph S Ross^{1

2}

Affiliations

¹ Section of General Internal Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
² Associate Editor, , Chicago, Illinois.

PMID: 30264093
DOI: 10.1001/jamainternmed.2018.3930

No abstract available

PubMed Disclaimer

Comment on

Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.
Moore TJ, Zhang H, Anderson G, Alexander GC. Moore TJ, et al. JAMA Intern Med. 2018 Nov 1;178(11):1451-1457. doi: 10.1001/jamainternmed.2018.3931. JAMA Intern Med. 2018. PMID: 30264133 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations